Document is current
Any future updates will be listed below
-
Authors
Mori, Shuuichi
Omura, Takuya
Kono, Mako
Fukunaga, Taichi
Koseki, Haruhiko
Shigemoto, Kazuhiro
-
Funding
Funding for this research was provided by:
Grant-in-Aid for Scientific Research (20800079, 20K19737, 25670437, 16H03266, 19H04064)
Grants-in-Aid for Scientific Research on Innovative Area (21200023)
AMED Leap (JP21mg00100007)
Takeda Science Foundation
- License Information
-
More Information
Article History
Received: 28 October 2024
Accepted: 26 March 2025
First Online: 3 April 2025
Declarations
:
: KS is an inventor of three issued patents titled “Muscle stem cell or myoblast, method for screening substances that participate in metabolic conversion using same, and pharmaceutical composition comprising substance obtained from said screening method” (JP6159930, US9618502B2 and EP3061810B1). TF is a current employee of Daiichi-Sankyo Co., Ltd. SM, TO, MK and HK have no competing interests.
